Springer Nature OA
open access
CC BY 4.0
Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MUTANT P53 AS A THERAPEUTIC TARGET IN CANCER#263702
- Nitric oxide dual-enhanced nanosystem boosts ferroptosis-chemotherapy synergy for tumor therapy.#236174
- Ferroptosis Signature Correlates with Ovarian Cancer Prognosis and Chemotherapy Response.#368045
- Pharmacological targets for the induction of ferroptosis : Focus on Neuroblastoma and Glioblastoma#647592
- FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors#279502
Record · ID 626794
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive